As of 2024-12-14, the Fair Value of Stoke Therapeutics Inc (STOK) is -9.95 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 12.06 USD, the upside of Stoke Therapeutics Inc is -182.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -32.33 | -52.24 | -85.81 | -101.07 | -104.70 | -75.23 |
| YoY growth | -158.23% | -61.58% | -64.26% | -17.78% | -3.59% | -61.09% |
| Market Cap (mil) | 638.82 |
| P/E | |
| Forward P/E |
| EPS | -1.99 |
| Avg earnings growth rate | -61.09% |
| TTM earnings | -105.46 |